Filter

Refine by collections

  • Cardiovascular (4)

Refine by date

—
  • Print
  • Save

Search Results

You are looking at 1 - 4 of 4 items for :

  • Cardiovascular x
Clear All
Eng-Loon Tng Department of Medicine, Level 8, Tower A, Ng Teng Fong General Hospital, Singapore

Search for other papers by Eng-Loon Tng in
Google Scholar
PubMed Close
,
Yee Sian Tiong Department of Medicine, Level 8, Tower A, Ng Teng Fong General Hospital, Singapore

Search for other papers by Yee Sian Tiong in
Google Scholar
PubMed Close
,
Aye Thida Aung Department of Medicine, Level 8, Tower A, Ng Teng Fong General Hospital, Singapore

Search for other papers by Aye Thida Aung in
Google Scholar
PubMed Close
,
Nicole Ya Yuan Chong Department of Medicine, National University Hospital, Singapore

Search for other papers by Nicole Ya Yuan Chong in
Google Scholar
PubMed Close
, and
Zhemin Wang Department of Medicine, National University Hospital, Singapore

Search for other papers by Zhemin Wang in
Google Scholar
PubMed Close

efficacy and safety of anticoagulation in people with TAF. The secondary objectives are frequency of intracranial hemorrhage (ICH), gastrointestinal bleeding (GIB), and quality of life in people with TAF with and without anticoagulation. Methods

Article Type:
Research Article
Collections:
Cardiovascular
DOI:
https://doi.org/10.1530/EC-22-0166
Volume/Issue:
Volume 11: Issue 5
Open access
Henrik Ryberg Department of Clinical Chemistry, Sahlgrenska University Hospital, Gothenburg, Sweden
Sahlgrenska Osteoporosis Centre, Center for Bone and Arthritis Research (CBAR), Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden

Search for other papers by Henrik Ryberg in
Google Scholar
PubMed Close
,
Anna-Karin Norlén Department of Clinical Chemistry, Sahlgrenska University Hospital, Gothenburg, Sweden
Sahlgrenska Osteoporosis Centre, Center for Bone and Arthritis Research (CBAR), Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden

Search for other papers by Anna-Karin Norlén in
Google Scholar
PubMed Close
,
Andreas Landin Department of Clinical Chemistry, Sahlgrenska University Hospital, Gothenburg, Sweden
Sahlgrenska Osteoporosis Centre, Center for Bone and Arthritis Research (CBAR), Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden

Search for other papers by Andreas Landin in
Google Scholar
PubMed Close
,
Per Johansson Sahlgrenska Osteoporosis Centre, Center for Bone and Arthritis Research (CBAR), Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden

Search for other papers by Per Johansson in
Google Scholar
PubMed Close
,
Zeinab Salman Sahlgrenska Osteoporosis Centre, Center for Bone and Arthritis Research (CBAR), Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden

Search for other papers by Zeinab Salman in
Google Scholar
PubMed Close
,
Anders Wallin Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Mölndal, Sweden

Search for other papers by Anders Wallin in
Google Scholar
PubMed Close
,
Johan Svensson Sahlgrenska Osteoporosis Centre, Center for Bone and Arthritis Research (CBAR), Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden
Department of Endocrinology, Skaraborg Central Hospital, Skövde, Sweden

Search for other papers by Johan Svensson in
Google Scholar
PubMed Close
, and
Claes Ohlsson Sahlgrenska Osteoporosis Centre, Center for Bone and Arthritis Research (CBAR), Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden

Search for other papers by Claes Ohlsson in
Google Scholar
PubMed Close

.2→167.0. All peaks were automatically integrated using the MassHunter quantitative analysis Workstation Software (version 10.1) from Agilent. Quality control For every batch analyzed, external quality controls were included that consisted of pooled

Article Type:
Research Article
Collections:
Cardiovascular
DOI:
https://doi.org/10.1530/EC-23-0250
Volume/Issue:
Volume 13: Issue 1
Open access
Charlotte Höybye Department of Endocrinology and Department of Molecular Medicine and Surgery, Karolinska University Hospital and Karolinska Institute, Stockholm, Sweden

Search for other papers by Charlotte Höybye in
Google Scholar
PubMed Close
,
Beverly M K Biller Neuroendocrine Unit, Massachusetts General Hospital, Massachusetts General Hospital, Boston, Massachusetts, USA

Search for other papers by Beverly M K Biller in
Google Scholar
PubMed Close
,
Jean-Marc Ferran Qualiance ApS, Copenhagen, Denmark

Search for other papers by Jean-Marc Ferran in
Google Scholar
PubMed Close
,
Murray B Gordon Allegheny Neuroendocrinology Center, Division of Endocrinology, Allegheny General Hospital, Pittsburgh, Pennsylvania, USA

Search for other papers by Murray B Gordon in
Google Scholar
PubMed Close
,
Nicky Kelepouris US Medical Affairs-Rare Endocrine Disorders, Novo Nordisk, Inc, Plainsboro, New Jersey, USA

Search for other papers by Nicky Kelepouris in
Google Scholar
PubMed Close
,
Navid Nedjatian Global Medical Affairs – Rare Endocrine Disorders, Novo Nordisk Health Care AG, Zurich, Switzerland

Search for other papers by Navid Nedjatian in
Google Scholar
PubMed Close
,
Anne H Olsen Epidemiology, Novo Nordisk A/S, Soborg, Denmark

Search for other papers by Anne H Olsen in
Google Scholar
PubMed Close
, and
Matthias M Weber Unit of Endocrinology, 1, Medical Department, University Hospital, Universitätsmedizin Mainz, der Johannes Gutenberg-Universität, Mainz, Germany

Search for other papers by Matthias M Weber in
Google Scholar
PubMed Close

quality of life, an adverse lipid profile and an increased risk for cardiovascular (CV)-associated disease, diabetes and metabolic syndrome vs healthy adults ( 4 , 5 , 6 , 7 ). The use of growth hormone (GH) replacement therapy in AGHD has been shown

Article Type:
Research Article
Collections:
Cardiovascular
DOI:
https://doi.org/10.1530/EC-22-0267
Volume/Issue:
Volume 12: Issue 1
Open access
Paweł Komarnicki Department of Endocrinology, Metabolism and Internal Diseases, Poznan University of Medical Sciences, Poznań, Poland

Search for other papers by Paweł Komarnicki in
Google Scholar
PubMed Close
,
Paweł Gut Department of Endocrinology, Metabolism and Internal Diseases, Poznan University of Medical Sciences, Poznań, Poland

Search for other papers by Paweł Gut in
Google Scholar
PubMed Close
,
Jan Musiałkiewicz Department of Endocrinology, Metabolism and Internal Diseases, Poznan University of Medical Sciences, Poznań, Poland

Search for other papers by Jan Musiałkiewicz in
Google Scholar
PubMed Close
,
Maja Cieślewicz Department of Endocrinology, Metabolism and Internal Diseases, Poznan University of Medical Sciences, Poznań, Poland

Search for other papers by Maja Cieślewicz in
Google Scholar
PubMed Close
,
Adam Maciejewski Department of Endocrinology, Metabolism and Internal Diseases, Poznan University of Medical Sciences, Poznań, Poland

Search for other papers by Adam Maciejewski in
Google Scholar
PubMed Close
,
Prachi Patel Department of Endocrinology, Metabolism and Internal Diseases, Poznan University of Medical Sciences, Poznań, Poland

Search for other papers by Prachi Patel in
Google Scholar
PubMed Close
,
George Mastorakos Unit of Endocrinology, Diabetes Mellitus and Metabolism, Aretaieion University Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece

Search for other papers by George Mastorakos in
Google Scholar
PubMed Close
, and
Marek Ruchała Department of Endocrinology, Metabolism and Internal Diseases, Poznan University of Medical Sciences, Poznań, Poland

Search for other papers by Marek Ruchała in
Google Scholar
PubMed Close

usually benign character of NETs, metastases (most often to the liver) are a relatively common occurrence, with a lifetime prevalence of 28–77%. Their presence is associated with worse prognosis and decreased quality of life ( 10 , 11 , 12 , 13 , 14

Article Type:
Research Article
Collections:
Cardiovascular
DOI:
https://doi.org/10.1530/EC-23-0249
Volume/Issue:
Volume 12: Issue 10
Open access